Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Sanofi ADR

1SAN
Current price
101.68 EUR +0.12 EUR (+0.12%)
Last closed 55.54 USD
ISIN US80105N1054
Sector Healthcare
Industry Drug Manufacturers - General
Exchange Borsa Italiana
Capitalization 141 732 528 128 USD
Yield for 12 month +2.63 %
1Y
3Y
5Y
10Y
15Y
1SAN
21.11.2021 - 28.11.2021

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France. Address: 46, avenue de la Grande Armée,, Paris, France, 75017

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

62.69 USD

P/E ratio

29.5426

Dividend Yield

3.67 %

Current Year

+47 293 031 223 USD

Last Year

+49 839 410 127 USD

Current Quarter

+23 288 551 177 USD

Last Quarter

+12 208 124 475 USD

Current Year

+29 096 139 804 USD

Last Year

+34 801 609 742 USD

Current Quarter

+15 768 003 909 USD

Last Quarter

+8 431 929 110 USD

Key Figures 1SAN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 11 754 000 384 USD
Operating Margin TTM 14.31 %
PE Ratio 29.5426
Return On Assets TTM 4.16 %
PEG Ratio 0.8159
Return On Equity TTM 5.82 %
Wall Street Target Price 62.69 USD
Revenue TTM 47 080 001 536 USD
Book Value 58.1 USD
Revenue Per Share TTM
Dividend Share 3.76 USD
Quarterly Revenue Growth YOY 7.5 %
Dividend Yield 3.67 %
Gross Profit TTM 31 697 000 000 USD
Earnings per share 1.88 USD
Diluted Eps TTM 1.88 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -22.8 %
Profit Margin 8.95 %

Dividend Analytics 1SAN

Dividend growth over 5 years

2 %

Continuous growth

2 years

Payout Ratio 5 years average

71 %

Dividend History 1SAN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 2.04
Ex Dividend Date 09.05.2024
Forward Annual Dividend Yield 3.67 %
Last Split Factor 5:1
Payout Ratio 36.64 %
Last Split Date 30.09.2013
Dividend Date 06.06.2024

Stock Valuation 1SAN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 29.5426
Forward PE 11.2613
Enterprise Value Revenue 3.0599
Price Sales TTM 3.0105
Enterprise Value EBITDA 13.4488
Price Book MRQ 1.7143

Financials 1SAN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 1SAN

For 52 weeks

42.63 USD 58.97 USD
50 Day MA 55.4 USD
Shares Short Prior Month 11 124 360
200 Day MA 50.42 USD
Short Ratio 6.64
Shares Short 10 762 826
Short Percent 0.48 %